In India, cutting edge diagnostics are gaining ground in early cancer identification, leveraging advanced technologies like ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

Those samples can then be checked for cancer under a microscope. But systematic biopsies can be problematic. A major concern is that they overdiagnose low-grade, slow-growing tumors that might never ...

Corvus Pharmaceuticals Inc. (CRVS) announced new data highlighting the potential of ciforadenant, the Company's adenosine A2A ...

Pokimane opens up about a recent health scare involving a chest lump, sharing her anxiety over multiple biopsies.

While the overall 5-year survival rate is 97%, that number goes down significantly if the cancer has spread to distant parts ...

Nanoparticle-directed therapy has shown significant promise for treating localised prostate cancer, achieving tumour ablation ...

A surgical program at Health has been designated a United States Case Observation Site, meaning surgeons from around the U.S. can come to Health to learn about advanced robotic surgery techniques.

The Patent Eligibility and Restoration Act (PERA) would remove the current court-imposed restrictions on patent eligibility.

This year alone, more than 234,000 people in the U.S. will be diagnosed with the third most-common cancer type: lung cancer.

University College Dublin (UCD) researcher Dr Nicola Fletcher has received a coveted European Research Council (ERC) Synergy ...